NEUROPACE INC (NPCE)
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation
CoStar Group to Acquire Zonda, the Leader in New Home Data, Analytics, and Online Marketplaces
Okta to Present at Upcoming Investor Conferences
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma
Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds
Raydium Surpasses $1T in Volume Following Robinhood and Revolut Listings
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
Best Buy Announces Regular Quarterly Cash Dividend
DarkIris Announces Commercial Launch of AIGC Video Platform, video.aideptus.com, Integrating ByteDance’s Seedance 2.0 Model